
Cardinal Health (CAH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
60.2B
Gross Profit
2.2B
3.66%
Operating Income
585.0M
0.97%
Net Income
243.0M
0.40%
EPS (Diluted)
$1.00
Balance Sheet Metrics
Total Assets
53.1B
Total Liabilities
55.8B
Shareholders Equity
-2.6B
Cash Flow Metrics
Operating Cash Flow
1.3B
Free Cash Flow
1.3B
Revenue & Profitability Trend
Cardinal Health Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 222.6B | 226.8B | 205.0B | 181.3B | 162.5B |
Cost of Goods Sold | 214.4B | 219.4B | 198.1B | 174.8B | 155.7B |
Gross Profit | 8.2B | 7.4B | 6.9B | 6.5B | 6.8B |
Gross Margin % | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 5.4B | 5.0B | 4.8B | 4.5B | 4.5B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 5.4B | 5.0B | 4.8B | 4.5B | 4.5B |
Operating Income | 2.3B | 2.1B | 1.8B | 1.6B | 1.8B |
Operating Margin % | 1.0% | 0.9% | 0.9% | 0.9% | 1.1% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 215.0M | 51.0M | 84.0M | 147.0M | 180.0M |
Other Non-Operating Income | -6.0M | -878.0M | -1.0B | -2.3B | -1.3B |
Pre-tax Income | 2.1B | 1.2B | 663.0M | -784.0M | 323.0M |
Income Tax | 532.0M | 348.0M | 332.0M | 153.0M | -289.0M |
Effective Tax Rate % | 25.3% | 29.0% | 50.1% | 0.0% | -89.5% |
Net Income | 1.6B | 853.0M | 331.0M | -937.0M | 612.0M |
Net Margin % | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% |
Key Metrics | |||||
EBITDA | 3.2B | 2.8B | 2.5B | 2.3B | 2.6B |
EPS (Basic) | $6.48 | $3.48 | $1.27 | $-3.35 | $2.09 |
EPS (Diluted) | $6.45 | $3.45 | $1.26 | $-3.35 | $2.08 |
Basic Shares Outstanding | 241000000 | 245000000 | 261000000 | 279000000 | 292000000 |
Diluted Shares Outstanding | 241000000 | 245000000 | 261000000 | 279000000 | 292000000 |
Income Statement Trend
Cardinal Health Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.9B | 5.1B | 4.1B | 4.7B | 3.4B |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 13.2B | 12.1B | 11.1B | 10.6B | 9.1B |
Inventory | 16.8B | 15.0B | 16.1B | 15.6B | 14.6B |
Other Current Assets | 2.4B | 2.7B | 2.3B | 2.0B | 2.8B |
Total Current Assets | 36.4B | 34.9B | 33.7B | 32.9B | 31.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.2B | 1.9B | 1.8B | 1.7B | 1.7B |
Goodwill | 21.4B | 11.2B | 10.7B | 13.5B | 18.1B |
Intangible Assets | 2.9B | 1.7B | 1.5B | 1.8B | 2.1B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.7B | 1.3B | 1.1B | 953.0M | 951.0M |
Total Non-Current Assets | 16.7B | 10.2B | 9.6B | 10.9B | 13.4B |
Total Assets | 53.1B | 45.1B | 43.3B | 43.9B | 44.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 34.7B | 31.8B | 29.9B | 27.1B | 23.7B |
Short-term Debt | 550.0M | 434.0M | 792.0M | 580.0M | 871.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | 42.0M | - | 96.0M |
Total Current Liabilities | 38.9B | 35.6B | 33.7B | 30.6B | 27.6B |
Non-Current Liabilities | |||||
Long-term Debt | 8.0B | 4.7B | 3.9B | 4.7B | 5.4B |
Deferred Tax Liabilities | - | - | 8.7B | 9.3B | 9.7B |
Other Non-Current Liabilities | 8.9B | 8.0B | 8.7B | 9.3B | 9.7B |
Total Non-Current Liabilities | 16.9B | 12.7B | 12.6B | 14.0B | 15.0B |
Total Liabilities | 55.8B | 48.3B | 46.3B | 44.6B | 42.7B |
Equity | |||||
Common Stock | 3.0B | 2.9B | 2.7B | 2.8B | 2.8B |
Retained Earnings | 783.0M | -286.0M | -642.0M | -280.0M | 1.2B |
Treasury Stock | 6.4B | 5.7B | 4.9B | 3.1B | 2.2B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | -2.6B | -3.2B | -3.0B | -706.0M | 1.8B |
Key Metrics | |||||
Total Debt | 8.5B | 5.1B | 4.7B | 5.3B | 6.2B |
Working Capital | -2.5B | -756.0M | -3.0M | 2.4B | 3.4B |
Balance Sheet Composition
Cardinal Health Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.6B | 853.0M | 331.0M | -937.0M | 612.0M |
Depreciation & Amortization | 790.0M | 710.0M | 692.0M | 692.0M | 783.0M |
Stock-Based Compensation | 244.0M | 121.0M | 96.0M | 81.0M | 89.0M |
Working Capital Changes | 83.0M | 1.9B | 1.5B | 946.0M | -163.0M |
Operating Cash Flow | 2.9B | 3.5B | 2.5B | 796.0M | 1.8B |
Investing Activities | |||||
Capital Expenditures | -547.0M | -499.0M | -469.0M | -356.0M | -400.0M |
Acquisitions | -5.2B | -1.2B | -10.0M | 901.0M | -3.0M |
Investment Purchases | 0 | -554.0M | -7.0M | -78.0M | -22.0M |
Investment Sales | 202.0M | 385.0M | 32.0M | 100.0M | 47.0M |
Investing Cash Flow | -5.6B | -1.8B | -454.0M | 567.0M | -378.0M |
Financing Activities | |||||
Share Repurchases | -765.0M | -750.0M | -2.0B | -1.0B | -200.0M |
Dividends Paid | -494.0M | -499.0M | -525.0M | -559.0M | -573.0M |
Debt Issuance | 3.7B | 1.1B | 0 | 0 | - |
Debt Repayment | -445.0M | -783.0M | -579.0M | -885.0M | -570.0M |
Financing Cash Flow | 1.9B | -847.0M | -3.1B | -2.5B | -1.3B |
Free Cash Flow | 1.8B | 3.3B | 2.4B | 2.8B | 2.0B |
Net Change in Cash | -724.0M | 827.0M | -972.0M | -1.1B | 122.0M |
Cash Flow Trend
Cardinal Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.20
Forward P/E
17.32
Price to Book
-13.52
Price to Sales
0.16
PEG Ratio
4.45
Profitability Ratios
Profit Margin
0.70%
Operating Margin
1.05%
Return on Equity
-59.26%
Return on Assets
3.16%
Financial Health
Current Ratio
0.94
Debt to Equity
-3.56
Beta
0.68
Per Share Data
EPS (TTM)
$6.45
Book Value per Share
$-11.64
Revenue per Share
$923.56
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cah | 35.7B | 23.20 | -13.52 | -59.26% | 0.70% | -3.56 |
McKesson | 84.2B | 27.10 | -100.73 | -194.51% | 0.84% | -11.52 |
Cencora | 56.7B | 33.80 | 55.93 | 141.78% | 0.55% | 827.73 |
Henry Schein | 8.2B | 21.79 | 2.40 | 8.12% | 3.05% | 68.55 |
Patterson Companies | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
Owens & Minor | 408.6M | -1.11 | -1.44 | -148.42% | -11.18% | -7.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.